Fda

B3 WED ASTR fda Tape GG.jpg

Conflicts and red tape at the Food and Drug Administration (FDA) illustration by Greg Groesch / The Washington Times

B1 McCullough1.jpg

The Food and Drug Administration (FDA) and Big Pharma in the health care industry illustration by Alexander Hunter/The Washington Times

The Biden administration said Wednesday it is looking at putting artificial intelligence “nutrition labels” on new tech products similar to the Food and Drug Administration’s mandatory food labeling regime.

AI label 1.png

The Biden administration said Wednesday it is looking at putting artificial intelligence “nutrition labels” on new tech products similar to the Food and Drug Administration’s mandatory food labeling regime.

B3-ROFF-Flying-FDA-GG.jpg

Food and Drug Administration (FDA) Bureaucrats Illustration by Greg Groesch/The Washington Times

fda_chief_challenges_38199.jpg

In this Dec. 10, 2020, file photo, a sign is displayed for the Food and Drug Administration in Silver Spring, Md. (AP Photo/Manuel Balce Ceneta, File) **FILE**

nutrition_facts-fiber_74646.jpg

FILE - This file photo provided by the Food and Drug Administration shows a side-by-side comparison of the old, left, and new food Nutrition Facts labels. The revamped Nutrition Facts panel that the FDA announced on Tuesday, June 13, 2017, was being delayed, could also change what companies get to count as fiber. The FDA hasn’t yet cleared 26 ingredients that the industry can currently count as fiber to continue being counted as fiber on the new panel. The unsettled details are partly why the industry has called for delaying the deadline to use the new panel. Others say extending the deadline will only lead to confusion. (Food and Drug Administration via AP, File)

nutrition_facts_panel_16159.jpg

This photo provided by the Food and Drug Administration shows a side-by-side comparison of the old, left, and new food nutrition facts labels. The FDA says it intends to delay a rule that would require food companies to label their products with a revised nutrition facts panel. The agency had previously set a deadline of July 26, 2018, for the new panel, which was intended to make it easier for people to understand how much they’re eating. After hearing feedback from industry and others, the FDA said it would delay the compliance date. (Food and Drug Administration via AP)

fda_pulling_painkiller_59294.jpg

This Oct. 14, 2015, file photo shows the Food and Drug Administration campus in Silver Spring, Md.

FDA Commissioner.JPEG-0508a.jpg

In this Nov. 17, 2015, file photo, Dr. Robert Califf, President Obama's then-nominee to lead the Food and Drug Administration (FDA), testifies on Capitol Hill in Washington. The Senate confirmed Califf to be commissioner of the FDA. (AP Photo/Pablo Martinez Monsivais, File)

99554541f6457418780f6a706700d259.jpg

The panel of Food and Drug Administration advisers voted 18-6 in favor of Sprout Pharmaceutical's daily pill, flibanserin, on the condition that the company develops a plan to manage its risks. (Associated Press)

6d29f5a77915352f670f6a7067006626.jpg

This is a screen shot of the Food and Drug Administration (FDA) webpage. Pregnant and worried about your medication? The FDA is revamping confusing labels on prescription drugs to make it easier to understand which are safe to use. Women who are pregnant or breastfeeding often agonize over whether a drug needed for their own health might hurt their baby, or even if the woman's changing body requires a higher or lower dose. (AP Photo/FDA)

7_202014_ap8377515033788201.jpg

House Oversight Committee Chairman Rep. Darrell Issa, California Republican, is concerned that a new Food and Drug Administration rule that would allow generic drug companies to change warning labels without approval has no health benefits, and was designed to placate special interest groups and could increase lawsuits. (Associated Press)

552b19c9fcc4950b4f0f6a706700f0e9.jpg

FILE - In this April 11, 2012, file photo, poults raised without the use of antibiotics are seen at David Martin's turkey farm, in Lebanon, Pa. Twenty-five pharmaceutical companies are voluntarily phasing out the use of antibiotics for growth promotion in animals processed for meat, the Food and Drug Administration said Wednesday, March 26, 2014. Citing a potential threat to public health, the agency in December 2013 asked 26 companies to voluntarily stop labeling drugs important for treating human infection as acceptable for use in animal production. The FDA did not name the one company that has not agreed to withdraw or revise its drugs. (AP Photo/Matt Rourke, File)